Health-related characteristics of adult PLWH in selected Hospitals of Southern Ethiopia, 2022

VariableFrequency (n = 520)Percent (%)
WHO clinical stage
    Stage I47892
    Stage II194
    Stage III183
    Stage IV51
ART regimen started
    AZT-3TC-EFV8716.7
    AZT-3TC-NVP9318
    TDF-3TC-EFV26851.5
    Others7213.8
Duration of ART in months
    < 2414929
    ≥ 2437171
CD4 count (n = 450 patients)
    < 2004510
    200–3496514.5
    350–4997717.1
    ≥ 50026358.4
Regular physical exercise
    Yes24247
    No27853
History of alcohol consumption
    Yes6412
    No45688
History of cigarette smoking
    Yes71
    No51399
BMI
    Underweight (< 18.5)7715
    Normal weight (18.5–24.9)30759
    Overweight (25–30)10019
    Obesity (> 30)367
Dietary diversity score
    Low28555
    High23545
Household food security
    Secured11722.5
    Insecure40377.5

PLWH: people living with human immunodeficiency virus; ART: antiretroviral therapy; BMI: body mass index; AZT-3TC-EFV: Zidovudine-Lamivudine-Efavirenz; AZT-3TC-NVP: Zidovudine-Lamivudine-Nevirapine; TDF-3TC-EFV: Tenofovir Disoproxil Fumarate-Lamivudine-Efavirenz